XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.559
+0.039 (1.55%)
At close: Sep 11, 2026, 4:00 PM EDT
2.540
-0.019 (-0.74%)
After-hours: Sep 11, 2026, 6:26 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $8.35 million as of September 11, 2026. Its market cap has decreased by -32.99% in one year.
Market Cap
8.35M
Enterprise Value
8.27M
1-Year Change
-32.99%
Ranking
Category
Stock Price
$2.56
ChartMarket Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $8.35M, a decrease of -95.62%. That is a compound annual growth rate of -13.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 8.35M | 17.20% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 9.25M |
| Exicure | 9.16M |
| Xenetic Biosciences | 9.14M |
| Skye Bioscience | 9.03M |
| Traws Pharma | 8.67M |
| CNS Pharmaceuticals | 8.53M |
| Imunon | 8.25M |
| Alzamend Neuro | 8.24M |